SUNNYVALE, Calif. , Aug. 2, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the "2016 Notes"). The 2016 Notes were settled on August 1, 2016 for cash
SUNNYVALE, Calif. , July 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patients treated with the TomoTherapy® System.
User Satisfaction Ratings Exceed Industry Average for 11 Consecutive Quarters SUNNYVALE, Calif. , July 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its CyberKnife ® and TomoTherapy ® Systems continue to set the standard for overall user satisfaction. The
SUNNYVALE, Calif. , July 7, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2016 on Wednesday, August 17, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m.
Next Generation "Smart" System Enables Clinicians to Provide Highly Precise Treatment, Efficiently, for More Patients, Every Day SUNNYVALE, Calif. , June 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received 510(k) clearance from the U.S.
System Dedicated Solely to Breast Cancer Care Provides Excellent Clinical Outcomes SUNNYVALE, Calif. , June 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Fundación de Cancer de Mama in México City (FUCAM) has treated 1,000 breast cancer patients with the
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments SUNNYVALE, Calif. , June 16, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a
SUNNYVALE, Calif. , May 25, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine , President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on Friday, June 10, 2016 at 8:00 a.m. ET .
SUNNYVALE, Calif. , May 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City . Presentations will begin at 8:30 a.m.
Collaboration Designed to Expand Clinical Versatility of the CyberKnife® System with Addition of medPhoton Novel Imaging Solution SUNNYVALE, Calif. , May 1, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with medPhoton GmbH to
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
